Jennison Associates LLC Argenx Se Transaction History
Jennison Associates LLC
- $160 Billion
- Q3 2024
A detailed history of Jennison Associates LLC transactions in Argenx Se stock. As of the latest transaction made, Jennison Associates LLC holds 237,966 shares of ARGX stock, worth $150 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
237,966
Previous 236,438
0.65%
Holding current value
$150 Million
Previous $102 Million
26.93%
% of portfolio
0.08%
Previous 0.07%
Shares
29 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.66 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.21 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.56 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.07 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$778 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $34.8B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...